Btk function in B cell development and responsee

Seminars in Immunology

Volumn 10, Issue 4, 1998, Pages 309-316

  Satterthwaite, Anne B ^a   Li, Zuomei ^a   Witte, Owen N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B cell antigen receptor (BCR); Bruton's tyrosine kinase (Btk); Immunodeficiency; Pleckstrin homology (PH) domain; Tyrosine phosphorylation

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE KINASE;

B LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNODEFICIENCY; CROSS LINKING; HUMAN; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; REVIEW;

EID: 0032147181     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0123     Document Type: Article

References (85)

1. 1. Goodnow CC (1996) Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 93:2264-2271
2. 2. Satterthwaite AB, Witte ON (1996) Lessons from human genetic variants in the study of B-cell differentiation. Curr Opinion Immunol 8:454-458
3. 3. Oka Y, Rolink AG, Andersson J, Kamanaka M, Uchida J, Yasui T, Kishimoto T, Kikutani H, Melchers F (1996) Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int Immunol 8:1675-1685
4. 4. Woodland RT, Schmidt MR, Korsmeyer SJ, Gravel KA (1996) Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. J Immunol 156:2143-2154
5. 5. Anderson JS, Teutsch M, Dong Z, Wortis HH (1996) An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis. Proc Natl Acad Sci USA 93:10966-10971
6. 6. Miyake K, Yamashita Y, Hitoshi Y, Takatsu K, Kimoto M (1994) Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med 180:1217-1224
7. 7. Kawakami Y, Miura T, Bissonnette R, Hata D, Khan WN, Kitamura T, Maeda-Yamamoto M, Hartman SE, Yao L, Alt FW, Kawakami T (1997) Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci USA 94:3938-3942
8. 8. Uckun FM, Waddick KG, Mahajan S, Jun X, Takata M, Bolen J, Kurosaki T (1996) BTK as a mediator of radiation-induced apoptosis in DT40 lymphomaB cells. Science 273:1096-1100
9. q -protein alpha-subunit. Nature 389:296-299
10. 10. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA (1996) Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci USA 93:13814-13818
11. 11. Satterthwaite AB, Cheroutre H, Khan WN, Sideras P, Witte ON (1997) Btk dosage determines sensitivity to B cell antigen receptor crosslinking. Proc Natl Acad Sci USA, 94:13152-13157
12. - B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. J Immunol 131:2107-2109
13. 13. Santos-Argumedo L, Lund FE, Heath AW, Solvason N, Wu WW, Grimaldi JC, Parkhouse RME, Howard M (1995) CD38 unresponsiveness of xid B cell implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int Immunol 7:163-170
14. 14. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, Tedder TF (1995) Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39-50
15. 15. Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-355
16. 16. Kishihara K, Penninger J, Wallace VA, Kündig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML, Furlonger C, Paige CJ, Mak TW (1993) Normal B lymphocyte development but impaired T cell maturation in CD45-Exon6 protein tyrosine phosphatase-deficient mice. Cell 74:143-156
17. 17. Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105-107
18. 18. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC (1996) Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381:325-328
19. 19. Wang J, Koizumi T, Watanabe T (1996) Altered antigen receptor signaling and impaired fas-mediated apoptosis of B cells in Lyn-deficient mice. J Exp Med 184:831-838
20. 20. Chan VWF, Meng F, Soriano P, DeFranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in lyn-deficient mice and the role of lyn in signal initiation and down-regulation. Immunity 7:69-81
21. 21. Lam K-P, Kuhn R, Rajewsky K (1997) In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073-1083
22. 22. Torres RM, Flaswinkel H, Reth M, Rajewsky K (1996) Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 272:1804-1808
23. 23. Aoki Y, Isselbacher KJ, Pillai S (1994) Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci USA 91:10606-10609
24. 24. de Weers M, Brouns GS, Hinshelwood S, Kinnon C, Schuurman RKB, Hendriks RW, Borst J (1994) B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J Biol Chem 269:23857-23860
25. 25. Saouaf SJ, Mahajan S, Rowley RB, Kut S, Fargnoli J, Burkhardt AL, Tsukada S, Witte ON, Bolen JB (1994) Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinase following B cell antigen receptor surface engagement. Proc Natl Acad Sci USA 91:9524-9528
26. 26. Hinshelwood S, Lovering RC, Genevier HC, Levinsky RJ, Kinnon C (1995) The protein defective in x-linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked. Eur J Immunol 25:1113-1116
27. 27. Sieckmann DG, Asofsky R, Mosier DE, Zitron IM, Paul WE (1978) Activation of mouse lymphocytes by anti-immunoglobulin. J Exp Med 147:814-829
28. 28. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP (1996) Activation of BTK by a phosphorylation mechanism initiated by Src family kinases. Science 271:822-825
29. 29. Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB (1995) Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol Cell Biol 15:5304-5311
30. 30. Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tarn C, Scharenberg AM, Kinet J-P, Witte ON (1996) Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4:515-525
31. 31. Kurosaki T, Kurosaki M (1997) Transphosphorylation of Bruton's tyrosine kinase on tyrosine Y551 is critical for B cell antigen receptor function. J Biol Chem 272:15595-15598
32. 2+ following B cell receptor activation. EMBO J, in press
33. 33. Li T, Tsukada S, Satterthwaite A, Havlik MH, Park H, Takatsu K, Witte ON (1995). Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2:451-460
34. 34. Afar DEH, Park H, Howell BW, Rawlings DJ, Cooper J, Witte ON (1996) Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol 16:3465-3471
35. 35. Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL (1997) Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 385:93-97
36. 36. Cory GOC, MacCarthy-Morrogh L, Banin S, Gout I, Brickell PM, Levinsky RJ, Kinnon C, Lovering RC (1996) Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J Immunol 157:3791-3795
37. 37. Cory GOC, Lovering RC, Hinshelwood S, MacCarthy-Morrogh L, Levinsky RJ, Kinnon C (1995) The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med 182:611-615
38. 38. Guinamard R, Fougereau M, Seckinger P (1997) The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Scand J Immunol 45:587-595
39. 39. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301-311
40. 40. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Llic D, Mori S, Watanabe T, Yamamoto T (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549-560
41. 41. Wahl MI, Fluckiger A-C, Kato RM, Park H, Witte ON, Rawlings DJ (1997) Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's Tyrosine Kinase via alternative receptors. Proc Natl Acad Sci USA 94:11526-11533
42. 42. Yasue T, Nishizumi H, Aizawa S, Yamamoto T, Miyake K, Mizoguchi C, Uehara S, Kikuchi Y, Takatsu K (1997) A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc Natl Acad Sci USA 94:10307-10312
43. 43. Appleby MW, Kerner JD, Chien S, Malieszewski CR, Bondada S, Perlmutter RM (1995) Involvement of p59fynT in interleukin-5 receptor signaling. J Exp Med 182:811-820
44. 44. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, Jenkins NA, Witte ON (1993) Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358-361
45. 45. Thomas JD, Sideras P, Smith CIE, Vorechovsky I, Chapman V, Paul WE (1993) Co-localization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355-358
46. 46. Tsukada S, Simon M, Witte O, Katz A (1994) Binding of the βγ subunits of heterotrimeric G-proteins to the PH domain of Bruton's tyrosine kinase. Proc Natl Acad Sci USA 91:11256-11260
47. 47. Touhara K, Inglese J, Pitcher JA, Shawi G, Lefkowitz RJ (1994) Binding of G protein βγ-subunits to pleckstrin homology domains. J Biol Chem 269:10217-10220
48. 48. Langhans-Rajasekaran SA, Wan Y, Huang X-Y (1995) Activation of Tsk and Btk tyrosine kinases by G protein βγ subunits. Proc Natl Acad Sci USA 92:8601-8605
49. 49. Salim K, Bottomley MJ, Querfurth E, Zvelebil MJ, Gout I, Scaife R, Margolis RL, Gigg R, Smith EIE, Driscoo PC, Waterfield MD, Panayotou G (1996) Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J 15:6241-6250
50. 50. Rameh LE, Arvidsson A-kristin, Carraway KL, Couvillon AD 3rd, Rathbun G, Crompton A, Van Renterghem B, Czech M, Ravichandra P, Kodimangalam S, Burakoff SJ, Wang D-S, Chen C-S, Cantley LC (1997) A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem 272:22059-22066
51. 51. Fukuda M, Kojima T, Kabayama H, Mikoshiba K (1996) Mutation of the pleckstrin homology domain of Bruton's Tyrosine Kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J Biol Chem 271:30303-30306
52. 52. Yao L, Kawakami Y, Kawakami T (1994) The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 91:9175-9179
53. 53. Yao L, Suzuki H, Ozawa K, Deng J, Lehel C, Fukamachi H, Anderson W, Kawakami Y, Kawakami T (1997) Interactions between protein kinase C and pleckstrin homology domains. J Biol Chem 272:13033-13039
54. 54. Li T, Rawlings DJ, Park H, Kato RM, Witte ON, Satterthwaite AB (1997) Constitutive membrane association potentiates activation of Bruton's tyrosine kinase. Oncogene 15:1375-1383
55. 55. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A (1996) Immunodeficiency in protein kinase C β-deficient mice. Science 273:788-791
56. 56. Tarakhovsky A (1997) Xid and Xid-like immunodeficiencies from a signaling point of view. Curr Opinion Immunol 9:319-323
57. 57. Sidorenko SP, Law C-L, Klaus SJ, Chandran KA, Takata M, Kurosaki T, Clark EA (1996) Protein kinase Cμ (PKCμ) associates with the B cell antigen receptor and regulates lymphocyte signaling. Immunity 5:353-363
58. 58. Toker A, Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676
59. 59. Vanhaesebroeck B, Leevers SJ, Panayotou G, Waterfield MD (1997) Phosphoinositide 3-kinases: a conserved family of signal transducers. TIBS 22:267-272
60. 60. Gold M, Chan V, Turck C, DeFranco A (1992) Membrane Ig cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes. J Immunol 148:2012-2022
61. 61. Gold MR, Aebersold R (1994) Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells. J Immunol 152:42-50
62. 62. Aagaard-Tillery KM, Jelinek DF (1996) Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. J Immunol 156:4543-4554
63. 63. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nurnberg B, Giershik P, Seedorf K, Hsuan JJ, Waterfield MD, Wetzker R (1995) Cloning and characterization of a G protein-activated human phosphoinositide-3. Science 269:690-693
64. 64. Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J, Smrcka AS, Thelen M, Cadwallader K, Tempst P, Hawkins PT (1997) The G βγ sensitivity of a P13K is dependent upon a tightly associated adaptor, p101. Cell 89:105-114
65. 65. Li Z, Wahl MI, Eguinoa A, Stephens LR, Hawkins PT, Witte ON (1997) Phosphatidylinositol 3-kinase-γ activates Bruton's tyrosine kinase in concert with Src family kinases. Proc Natl Acad Sci USA, 94:13820-13825
66. 66. Scharenberg AM, El-Hillal O, Fruman D, Li Z, Beitz LO, Lin S, Gout I, Waterfield MD, Witte ON, Cantley LC, Rawlings DJ, Kinet J-P (1997) Phosphatidylinositol-3,4,5-triphosphate (PtdIns-3,4,5-P3) controls calcium signaling by initiating TEC kinase-dependent activation of PLC γ. Submitted
67. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7:49-58
68. 68. Wan Y, Bence K, Hata A, Kurosaki T, Veillette A, Huang X-Y (1997) Genetic evidence for a tyrosine kinase cascade preceding the mitogen-activated protein kinase cascade in vertebrate G-protein signaling. J Biol Chem 272:17209-17215
69. 69. Kuruvilla A, Pielop C, Shearer WT (1994) Platelet-activating factor induces the tyrosine phosphorylation and activation of phospholipase C-γ 1, fyn and lyn kinases, and phosphatidylinositol 3-kinase in a human B cell line. J Immunol 153:1533-5442
70. 70. Toledano BJ, Bastien Y, Noya F, Baruchel S, Mazer B (1997) Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line. J Immunol 158:3705-3715
71. 71. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047
72. 72. Takata M, Kurosaki T (1996) A role for Bruton's Tyrosine Kinase in B cell antigen receptor-mediated activation of phospholipase C-γ 2. J Exp Med 184:31-40
73. 73. Padeh S, Levitzki A, Gazit A, Mills GB, Roifman CM (1991) Activation of phospholipase C in human B cells is dependent on tyrosine phosphorylation. J Clin Invest 87:1114-1118
74. ++ stores in B lymphocytes. J Immunol 137:708-714
75. 75. Rigley KP, Harnett MM, Phillips RJ, Klaus GGB (1989) Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice. Eur J Immunol 19:2081-2086
76. 76. Wilson HA, Greenblatt D, Taylor CW, Putney JW, Tsien RY, Finkelmna FD, Chused TM (1987) The B lymphocyte calcium response is diminished by membrane immunoglobulin crosslinkage to the Fc y receptor. J Immunol 138:1712-1718
77. 77. Choquet D, Partisetti M, Amigorena S, Bonnerot C, Fridman WH, Korn H (1993) Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol 121:355-363
78. 78. Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JB (1997) Deletion of SHIP-1 reveals two distinct pathways for inhibitory signaling. Cell 90:293-301
79. 79. Brorson K, Brunswick M, Ezhevsky S, Wei DG, Berg R, Scott D, Stein KE (1997) Xid affects events leading to B cell cycle entry. J Immunol 159:135-143
80. 80. Tooze RM, Doody GM, Fearon DT (1997) Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 7:59-67
81. 81. Li X, Sandoval D, Freeberg L, Carter RH (1997) Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J Immunol 158:5649-5657
82. 82. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR (1997) Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169-172
83. 83. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VLJ (1995) Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467-470
84. 84. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W (1995) Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-473
85. 85. Yang W, Desiderio S (1997) BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc Natl Acad Sci USA 94:604-609